Literature DB >> 27097965

Hyperoxia induces inflammation and regulates cytokine production in alveolar epithelium through TLR2/4-NF-κB-dependent mechanism.

D Huang1, F Fang, F Xu.   

Abstract

OBJECTIVE: It has been reported that inflammation of lung could be induced by proinflammatory factor under hyperoxia, which may be attributed by increasing generation of reactive oxygen species (ROS).
MATERIALS AND METHODS: In the present study, with human epithelial lung cancer cell line A549 treated with hyperoxia as in vitro model, we found that hyperoxia stimulation induced TLR2/4 activity in A549 cells. ROS inhibitor NAC was used to investigate the role of ROS in hyperoxia-induced inflammatory cytokines secretion.
RESULTS: Results of mRNA to protein level showed that elevated TLR2/4 activity and hyperoxia-induced inflammatory cytokines secretion could be significantly attenuated by NAC. EMSA results showed the activation of nuclear factor-κB (NF-κB) increased after 2-h hyperoxia stimulation, and the ROS inhibitor blocked TLR2/4 and NF-κB activity.
CONCLUSIONS: Data suggested that the TLR2/4-NF-κB pathway is involved in hyperoxia-induced inflammatory cytokines secretion in A549 human type II alveolar epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27097965

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  9 in total

1.  Oxidative Stress in the Lung - The Essential Paradox.

Authors:  Lynette K Rogers; Mary J Cismowski
Journal:  Curr Opin Toxicol       Date:  2017-09-19

2.  Lactoferrin Protects Hyperoxia-Induced Lung and Kidney Systemic Inflammation in an In Vivo Imaging Model of NF-κB/Luciferase Transgenic Mice.

Authors:  Chih-Ching Yen; Wen-Hui Chang; Min-Che Tung; Hsiao-Ling Chen; Hsu-Chung Liu; Chun-Huei Liao; Ying-Wei Lan; Kowit-Yu Chong; Shang-Hsun Yang; Chuan-Mu Chen
Journal:  Mol Imaging Biol       Date:  2020-06       Impact factor: 3.488

3.  Increased Serum Levels of Proinflammatory Cytokines Are Accompanied by Fatigue in Military T-6A Texan II Instructor Pilots.

Authors:  Elizabeth G Damato; Seth J Fillioe; Seunghee P Margevicius; Ryan S Mayes; Jonathan E Somogyi; Ian S Vannix; Alireza Abdollahifar; Anthony M Turner; Lidia S Ilcus; Michael J Decker
Journal:  Front Physiol       Date:  2022-04-28       Impact factor: 4.755

Review 4.  Implications of Hyperoxia over the Tumor Microenvironment: An Overview Highlighting the Importance of the Immune System.

Authors:  Ana Belén Herrera-Campos; Esteban Zamudio-Martinez; Daniel Delgado-Bellido; Mónica Fernández-Cortés; Luis M Montuenga; F Javier Oliver; Angel Garcia-Diaz
Journal:  Cancers (Basel)       Date:  2022-05-31       Impact factor: 6.575

5.  Vitamin D attenuates hyperoxia-induced lung injury through downregulation of Toll-like receptor 4.

Authors:  Li Yao; Yongyan Shi; Xinyi Zhao; Ana Hou; Yujiao Xing; Jianhua Fu; Xindong Xue
Journal:  Int J Mol Med       Date:  2017-04-21       Impact factor: 4.101

Review 6.  The Role of Oxidative Stress in Sarcoidosis.

Authors:  Sara Solveig Fois; Sara Canu; Alessandro Giuseppe Fois
Journal:  Int J Mol Sci       Date:  2021-10-28       Impact factor: 5.923

7.  Vitamin D Ameliorates Apoptosis and Inflammation by Targeting the Mitochondrial and MEK1/2-ERK1/2 Pathways in Hyperoxia-Induced Bronchopulmonary Dysplasia.

Authors:  Jinhui Hu; Zhixin Wu; Huawei Wang; Haifeng Geng; Jie Huo; Xueping Zhu; Xiaoli Zhu
Journal:  J Inflamm Res       Date:  2022-08-25

Review 8.  Oxygen toxicity: cellular mechanisms in normobaric hyperoxia.

Authors:  Ricardo Alva; Maha Mirza; Adam Baiton; Lucas Lazuran; Lyuda Samokysh; Ava Bobinski; Cale Cowan; Alvin Jaimon; Dede Obioru; Tala Al Makhoul; Jeffrey A Stuart
Journal:  Cell Biol Toxicol       Date:  2022-09-16       Impact factor: 6.819

9.  Correlation between the presence of circulating tumor cells and the pathologic type and staging of non-small cell lung cancer during the early postoperative period.

Authors:  Zhanqiang Xie; Xiaotian Gao; Keluo Cheng; Lishuang Yu
Journal:  Oncol Lett       Date:  2017-09-07       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.